Alpenglow Biosciences to present at BioCentury Grand Rounds: U.S. 2026

Alpenglow Biosciences is honored to be among the presenting companies at the 3rd BioCentury Grand Rounds: U.S., taking place June 3 to 5, 2026, in Seattle, Washington.

Nick Reder, MD, MPH, CEO of Alpenglow Biosciences, is scheduled to present on Thursday, June 4, 2026, at 10:20 AM at the Hyatt Regency Seattle.

The event brings together leaders across biotechnology, medicine, technology, and investment to discuss emerging innovation and company development. Alpenglow looks forward to contributing to the conversation and sharing its perspective on the growing role of 3D digital pathology, spatial biology, and AI-powered analysis in translational research.

Alpenglow is advancing high-resolution, whole-tissue 3D imaging and computational analysis to help researchers capture tissue architecture, spatial relationships, and biological patterns that are difficult to assess through traditional approaches.

Thank you to BioCentury for the invitation to present. The Alpenglow team looks forward to meaningful discussions with the BioCentury community in Seattle.